| Name | 6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxylic acid |
|---|
| Molecular Formula | C14H10F3NO3 |
|---|---|
| Molecular Weight | 297.22900 |
| Exact Mass | 297.06100 |
| PSA | 59.30000 |
| LogP | 2.86290 |
| HS Code | 2933399090 |
|---|
|
~56%
694479-56-6 |
| Literature: ASTRAZENECA AB Patent: WO2007/129962 A1, 2007 ; Location in patent: Page/Page column 50 ; WO 2007/129962 A1 |
|
~76%
694479-56-6 |
| Literature: AstraZeneca AB Patent: US2011/82155 A1, 2011 ; Location in patent: Page/Page column 23 ; US 20110082155 A1 |
|
~%
694479-56-6 |
| Literature: AstraZeneca AB Patent: US2011/82155 A1, 2011 ; US 20110082155 A1 |
| Precursor 4 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |